Atlas Trials

Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity

RecordFirmDate
Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision (NCT01053858)Hallym University Medical Center2008-01-01

Track Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity automatically

Every clearance here is in the API, with alerts when new ones post.